Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05933070 |
| Title | A Phase I Open-Label Dose Escalation Study of Intravenous INKmune In Patients With MDS or AML (LAUREL) |
| Acronym | LAUREL |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Inmune Bio, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | GRC | GBR |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Attikon University General Hospital | Athens | Attiki | 124 62 | Greece | Details | |
| University Hospital Southampton NHS Foundation Trust | Southampton | Hampshire | S016 6YD | United Kingdom | Details | |
| Sheffield Teaching Hospitals NHS FT - Royal Hallamshire Hospital | Sheffield | S10 2RX | United Kingdom | Details |